Phase II Study of Gemcitabine and Bevacizumab As First-Line Treatment in Taxane-Pretreated, HER2-Negative, Locally Recurrent or Metastatic Breast Cancer
作者
R. Borson,Graydon Harker,James A. Reeves,Thaddeus Beck,Steven Hager,William L. Horvath,Michael Jones,Guy W Tillinghast,Edward Arrowsmith,G Harrer,Fred J. Kudrik,S. Malamud,Jane Bromund,Haoyue Zeigler,D. F. Tai,Lori J. Kornberg,Coleman K. Obasaju,Mauro Orlando,Denise A. Yardley